Role of transient receptor potential vanilloid 1 in regulating erythropoietin-induced activation of endothelial nitric oxide synthase

Acta Physiologica

Volumn 219, Issue 2, 2017, Pages 465-477

  Yu, Y B ^a,b   Su, K H ^a,c   Kou, Y R ^a   Guo, B C ^a   Lee, K I ^a   Wei, J ^d   Lee, T S ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c JACKSON LABORATORY   (United States)

^d CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

angiogenesis; Ca2+; eNOS; erythropoietin; TRPV1

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ERYTHROPOIETIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NITRIC OXIDE; PHOSPHOLIPASE C GAMMA1; PROTEIN KINASE B; VANILLOID RECEPTOR 1; TRPV1 PROTEIN, MOUSE; VANILLOID RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; AORTIC ENDOTHELIAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE COMPLEX; HEK293 CELL LINE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ULTRAVIOLET SPECTROPHOTOMETRY; ANIMAL; BOVINE; C57BL MOUSE; DRUG EFFECTS; ENDOTHELIUM CELL; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; CATTLE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; ERYTHROPOIETIN; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; TRPV CATION CHANNELS;

EID: 84977493493     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12723     Document Type: Article

References (59)

1. Ahern, G.P., Brooks, I.M., Miyares, R.L. & Wang, X.B. 2005. Extracellular cations sensitize and gate capsaicin receptor TRPV1 modulating pain signaling. J Neurosci 25, 5109–5116.
2. Ahmmed, G.U. & Malik, A.B. 2005. Functional role of TRPC channels in the regulation of endothelial permeability. Pflugers Arch 451, 131–142.
3. Arnould, T., Michiels, C., Alexandre, I. & Remacle, J. 1992. Effect of hypoxia upon intracellular calcium concentration of human endothelial cells. J Cell Physiol 152, 215–221.
4. Baylie, R.L. & Brayden, J.E. 2011. TRPV channels and vascular function. Acta Physiol (Oxf) 203, 99–116.
5. Bodkin, J.V. & Brain, S.D. 2011. Transient receptor potential ankyrin 1: emerging pharmacology and indications for cardiovascular biology. Acta Physiol (Oxf) 203, 87–98.
6. Brayden, J.E., Earley, S., Nelson, M.T. & Reading, S. 2008. Transient receptor potential (TRP) channels, vascular tone and autoregulation of cerebral blood flow. Clin Exp Pharmacol Physiol 35, 1116–1120.
7. Burger, D., Lei, M., Geoghegan-Morphet, N., Lu, X., Xenocostas, A. & Feng, Q. 2006. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase. Cardiovasc Res 72, 51–59.
8. Carlini, R.G., Gupta, A., Liapis, H. & Rothstein, M. 1995. Endothelin-1 release by erythropoietin involves calcium signaling in endothelial cells. J Cardiovasc Pharmacol 26, 889–892.
9. Ching, L.C., Kou, Y.R., Shyue, S.K., Su, K.H., Wei, J., Cheng, L.C., Yu, Y.B., Pan, C.C. & Lee, T.S. 2011. Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1. Cardiovasc Res 91, 492–501.
10. Ching, L.C., Chen, C.Y., Su, K.H., Hou, H.H., Shyue, S.K., Kou, Y.R. & Lee, T.S. 2012. Implication of AMP-activated protein kinase in transient receptor potential vanilloid type 1-mediated activation of endothelial nitric oxide synthase. Mol Med 18, 805–815.
11. Ching, L.C., Zhao, J.F., Su, K.H., Shyue, S.K., Hsu, C.P., Lu, T.M., Lin, S.J. & Lee, T.S. 2013. Activation of transient receptor potential vanilloid 1 decreases endothelial nitric oxide synthase phosphorylation at Thr497 by protein phosphatase 2B-dependent dephosphorylation of protein kinase C. Acta Physiol (Oxf) 209, 124–135.
12. Dietrich, A., Kalwa, H. & Gudermann, T. 2010. TRPC channels in vascular cell function. Thromb Haemost 103, 262–270.
13. Fisher, J.W. 2003. Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood) 228, 1–14.
14. Fleming, I. & Busse, R. 1999. Signal transduction of eNOS activation. Cardiovasc Res 43, 532–541.
15. Guo, B.C., Wei, J., Su, K.H., Chiang, A.N., Zhao, J.F., Chen, H.Y., Shyue, S.K. & Lee, T.S. 2015. Transient receptor potential vanilloid type 1 is vital for (-)-epigallocatechin-3-gallate mediated activation of endothelial nitric oxide synthase. Mol Nutr Food Res 59, 646–657.
16. Hellwig, N., Albrecht, N., Harteneck, C., Schultz, G. & Schaefer, M. 2005. Homo- and heteromeric assembly of TRPV channel subunits. J Cell Sci 118, 917–928.
17. Hirschler-Laszkiewicz, I., Tong, Q., Waybill, K., Conrad, K., Keefer, K., Zhang, W., Chen, S.J., Cheung, J.Y. & Miller, B.A. 2011. The transient receptor potential (TRP) channel TRPC3 TRP domain and AMP-activated protein kinase binding site are required for TRPC3 activation by erythropoietin. J Biol Chem 286, 30636–30646.
18. Hirschler-Laszkiewicz, I., Zhang, W., Keefer, K., Conrad, K., Tong, Q., Chen, S.J., Bronson, S., Cheung, J.Y. & Miller, B.A. 2012. Trpc2 depletion protects red blood cells from oxidative stress-induced hemolysis. Exp Hematol 40, 71–83.
19. Imagawa, S., Smith, B.R., Palmer-Crocker, R. & Bunn, H.F. 1989. The effect of recombinant erythropoietin on intracellular free calcium in erythropoietin-responsive cells. Blood 73, 1452–1457.
20. Institute of Laboratory Animal Resources. 2011. Guide for the Care and Use of Laboratory Animals, eighth edition. National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. National Academies Press, Washington, DC.
21. Jin, X., Morsy, N., Winston, J., Pasricha, P.J., Garrett, K. & Akbarali, H.I. 2004. Modulation of TRPV1 by nonreceptor tyrosine kinase, c-Src kinase. Am J Physiol Cell Physiol 287, C558–C563.
22. Kone, B.C. 2000. Protein-protein interactions controlling nitric oxide synthases. Acta Physiol Scand 168, 27–31.
23. Li, L., Tucker, R.W., Hennings, H. & Yuspa, S.H. 1995. Chelation of intracellular Ca2+ inhibits murine keratinocyte differentiation in vitro. J Cell Physiol 163, 105–114.
24. Li, Y., Takemura, G., Okada, H., Miyata, S., Maruyama, R., Li, L., Higuchi, M., Minatoguchi, S., Fujiwara, T. & Fujiwara, H. 2006. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovasc Res 71, 684–694.
25. Lukacs, V., Thyagarajan, B., Varnai, P., Balla, A., Balla, T. & Rohacs, T. 2007. Dual regulation of TRPV1 by phosphoinositides. J Neurosci 27, 7070–7080.
26. Ma, L., Zhong, J., Zhao, Z., Luo, Z., Ma, S., Sun, J., He, H., Zhu, T., Liu, D., Zhu, Z. & Tepel, M. 2011. Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis. Cardiovasc Res 92, 504–513.
27. Marrero, M.B., Venema, R.C., Ma, H., Ling, B.N. & Eaton, D.C. 1998. Erythropoietin receptor-operated Ca2+ channels: activation by phospholipase C-gamma 1. Kidney Int 53, 1259–1268.
28. Miller, B.A., Scaduto, R.C. Jr, Tillotson, D.L., Botti, J.J. & Cheung, J.Y. 1988. Erythropoietin stimulates a rise in intracellular free calcium concentration in single early human erythroid precursors. J Clin Invest 82, 309–315.
29. Miller, B.A., Bell, L.L., Lynch, C.J. & Cheung, J.Y. 1994. Erythropoietin modulation of intracellular calcium: a role for tyrosine phosphorylation. Cell Calcium 16, 481–490.
30. Mohapatra, D.P. & Nau, C. 2005. Regulation of Ca2+-dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMP-dependent protein kinase. J Biol Chem 280, 13424–13432.
31. Mohapatra, D.P., Wang, S.Y., Wang, G.K. & Nau, C. 2003. A tyrosine residue in TM6 of the Vanilloid Receptor TRPV1 involved in desensitization and calcium permeability of capsaicin-activated currents. Mol Cell Neurosci 23, 314–324.
32. Mori, Y., Kajimoto, T., Nakao, A., Takahashi, N. & Kiyonaka, S. 2011. Receptor signaling integration by TRP channelsomes. Adv Exp Med Biol 704, 373–389.
33. Moriyama, T., Iida, T., Kobayashi, K., Higashi, T., Fukuoka, T., Tsumura, H., Leon, C., Suzuki, N., Inoue, K., Gachet, C., Noguchi, K. & Tominaga, M. 2003. Possible involvement of P2Y2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor 1-mediated thermal hypersensitivity. J Neurosci 23, 6058–6062.
34. Neusser, M., Tepel, M. & Zidek, W. 1993. Erythropoietin increases cytosolic free calcium concentration in vascular smooth muscle cells. Cardiovasc Res 27, 1233–1236.
35. Poblete, H., Oyarzun, I., Olivero, P., Comer, J., Zuniga, M., Sepulveda, R.V., Baez-Nieto, D., Gonzalez Leon, C., Gonzalez-Nilo, F. & Latorre, R. 2015. Molecular determinants of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) binding to transient receptor potential V1 (TRPV1) channels. J Biol Chem 290, 2086–2098.
36. Por, E.D., Samelson, B.K., Belugin, S., Akopian, A.N., Scott, J.D. & Jeske, N.A. 2010. PP2B/calcineurin-mediated desensitization of TRPV1 does not require AKAP150. Biochem J 432, 549–556.
37. Pozsgai, G., Bodkin, J.V., Graepel, R., Bevan, S., Andersson, D.A. & Brain, S.D. 2010. Evidence for the pathophysiological relevance of TRPA1 receptors in the cardiovascular system in vivo. Cardiovasc Res 87, 760–768.
38. Rebecchi, M.J. & Pentyala, S.N. 2000. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev 80, 1291–1335.
39. Ren, H.Y., Komatsu, N., Shimizu, R., Okada, K. & Miura, Y. 1994. Erythropoietin induces tyrosine phosphorylation and activation of phospholipase C-gamma 1 in a human erythropoietin-dependent cell line. J Biol Chem 269, 19633–19638.
40. Rohacs, T. 2015. Phosphoinositide regulation of TRPV1 revisited. Pflugers Arch 467, 1851–1869.
41. Rohacs, T., Thyagarajan, B. & Lukacs, V. 2008. Phospholipase C mediated modulation of TRPV1 channels. Mol Neurobiol 37, 153–163.
42. Salomonsson, M., Braunstein, T.H., Holstein-Rathlou, N.H. & Jensen, L.J. 2010. Na+-independent, nifedipine-resistant rat afferent arteriolar Ca2+ responses to noradrenaline: possible role of TRPC channels. Acta Physiol (Oxf) 200, 265–278.
43. Santhanam, A.V., d'Uscio, L.V. & Katusic, Z.S. 2010. Cardiovascular effects of erythropoietin an update. Adv Pharmacol, 60, 257–285.
44. Sautina, L., Sautin, Y., Beem, E., Zhou, Z., Schuler, A., Brennan, J., Zharikov, S.I., Diao, Y., Bungert, J. & Segal, M.S. 2010. Induction of nitric oxide by erythropoietin is mediated by the beta common receptor and requires interaction with VEGF receptor 2. Blood 115, 896–905.
45. Schaefer, A., Magocsi, M. & Marquardt, H. 1997. Signalling mechanisms in erythropoiesis: the enigmatic role of calcium. Cell Signal 9, 483–495.
46. Senadheera, S., Kim, Y., Grayson, T.H., Toemoe, S., Kochukov, M.Y., Abramowitz, J., Housley, G.D., Bertrand, R.L., Chadha, P.S., Bertrand, P.P., Murphy, T.V., Tare, M., Birnbaumer, L., Marrelli, S.P. & Sandow, S.L. 2012. Transient receptor potential canonical type 3 channels facilitate endothelium-derived hyperpolarization-mediated resistance artery vasodilator activity. Cardiovasc Res 95, 439–447.
47. Sessa, W.C. 2004. eNOS at a glance. J Cell Sci 117, 2427–2429.
48. Su, K.H., Shyue, S.K., Kou, Y.R., Ching, L.C., Chiang, A.N., Yu, Y.B., Chen, C.Y., Pan, C.C. & Lee, T.S. 2011. beta Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase. J Cell Physiol 226, 3330–3339.
49. Su, K.H., Yu, Y.B., Hou, H.H., Zhao, J.F., Kou, Y.R., Cheng, L.C., Shyue, S.K. & Lee, T.S. 2012. AMP-activated protein kinase mediates erythropoietin-induced activation of endothelial nitric oxide synthase. J Cell Physiol 227, 3053–3062.
50. Su, K.H., Lee, K.I., Shyue, S.K., Chen, H.Y., Wei, J. & Lee, T.S. 2014a. Implication of transient receptor potential vanilloid type 1 in 14,15-epoxyeicosatrienoic acid-induced angiogenesis. Int J Biol Sci 10, 990–996.
51. Su, K.H., Lin, S.J., Wei, J., Lee, K.I., Zhao, J.F., Shyue, S.K. & Lee, T.S. 2014b. The essential role of transient receptor potential vanilloid 1 in simvastatin-induced activation of endothelial nitric oxide synthase and angiogenesis. Acta Physiol (Oxf) 212, 191–204.
52. Tominaga, M. & Tominaga, T. 2005. Structure and function of TRPV1. Pflugers Arch 451, 143–150.
53. Tominaga, M., Wada, M. & Masu, M. 2001. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci USA 98, 6951–6956.
54. Tong, Q., Chu, X., Cheung, J.Y., Conrad, K., Stahl, R., Barber, D.L., Mignery, G. & Miller, B.A. 2004. Erythropoietin-modulated calcium influx through TRPC2 is mediated by phospholipase Cgamma and IP3R. Am J Physiol Cell Physiol 287, C1667–C1678.
55. Wei, J., Ching, L.C., Zhao, J.F., Shyue, S.K., Lee, H.F., Kou, Y.R. & Lee, T.S. 2013. Essential role of transient receptor potential vanilloid type 1 in evodiamine-mediated protection against atherosclerosis. Acta Physiol (Oxf) 207, 299–307.
56. Westenbrink, B.D., Ruifrok, W.P., Voors, A.A., Tilton, R.G., van Veldhuisen, D.J., Schoemaker, R.G., van Gilst, W.H. & de Boer, R.A. 2010. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure. Cardiovasc Res 87, 30–39.
57. Yang, D., Luo, Z., Ma, S., Wong, W.T., Ma, L., Zhong, J., He, H., Zhao, Z., Cao, T., Yan, Z., Liu, D., Arendshorst, W.J., Huang, Y., Tepel, M. & Zhu, Z. 2010. Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab 12, 130–141.
58. Yao, X. & Garland, C.J. 2005. Recent developments in vascular endothelial cell transient receptor potential channels. Circ Res 97, 853–863.
59. Zhou, Y., Lewis, T.L., Robinson, L.J., Brundage, K.M., Schafer, R., Martin, K.H., Blair, H.C., Soboloff, J. & Barnett, J.B. 2011. The role of calcium release activated calcium channels in osteoclast differentiation. J Cell Physiol 226, 1082–1089.